Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel - 3T/2R

Description:

The goal of the trial was to evaluate if tirofiban would reduce the incidence of myocardial infarction (MI) after percutaneous coronary intervention (PCI) among poor responders to aspirin and/or clopidogrel.